162 related articles for article (PubMed ID: 5325222)
21. Clinical trial of a new diuretic, bumetanide, in seriously ill patients.
Runeberg L; Pasternack A; Borgmästars H; von Bonsdorff M
Ann Clin Res; 1974 Oct; 6(5):272-8. PubMed ID: 4614693
[No Abstract] [Full Text] [Related]
22. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
Radó JP; Molnár Z; Hartai A; Gercsák G
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
[TBL] [Abstract][Full Text] [Related]
23. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Lowenthal DT; Shear L
Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
[No Abstract] [Full Text] [Related]
24. [Clinical observations on the efficacy of a new diuretic: furosemide].
Branciari C; Lauro G; Menghini G
Gazz Int Med Chir; 1965 Jul; 69(14):1203-14. PubMed ID: 5836956
[No Abstract] [Full Text] [Related]
25. [Clinical and biological study of a new diuretic: E 103 E].
Plauchu M; Bourlier V; Meunier P
Lyon Med; 1968 Jan; 219(4):275-8 passim. PubMed ID: 5664959
[No Abstract] [Full Text] [Related]
26. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
27. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
Furukawa T
Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
[No Abstract] [Full Text] [Related]
28. [Diuretic therapy in the course of hepatic cirrhosis with ascites].
Del Prete S
Osp Maggiore; 1965 Sep; 60(9):814-9. PubMed ID: 5850040
[No Abstract] [Full Text] [Related]
29. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
30. Use of diuretics in the treatment of cirrhotic ascites.
Boyer TD; Warnock DG
Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
[No Abstract] [Full Text] [Related]
31. [Biometric assay of the saluretic synergism of clopamide and furosemide].
Szám I; Sólyom I; Fischer J
Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):221-5. PubMed ID: 4902017
[No Abstract] [Full Text] [Related]
32. Comparative efficacy of spironolactone and hydrochlorothiazide (separately and in combination) in cirrhotic edema.
Munshi CP; Sawkar LA; Vaidya PM; Gulati OD
J Assoc Physicians India; 1967 Dec; 15(12):583-9. PubMed ID: 4870785
[No Abstract] [Full Text] [Related]
33. [Management of hepatic ascites using Fursemide].
Bemvenuti GA; Job JM
Hospital (Rio J); 1968 Nov; 74(5):1601-38. PubMed ID: 5305338
[No Abstract] [Full Text] [Related]
34. [Renal insufficiency caused by diuretics in liver cirrhosis with ascites].
Bosch J; Arroyo V; Rodes J; Teres J; Bordas JM; Bruguera M
Rev Clin Esp; 1973 Dec; 131(5):375-82. PubMed ID: 4779095
[No Abstract] [Full Text] [Related]
35. Bumetanide in the treatment of hepatic ascites.
Ring-Larsen H
Postgrad Med J; 1975; 51 Suppl 6():77-81. PubMed ID: 1105536
[No Abstract] [Full Text] [Related]
36. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
37. [Effect of diuretic therapy on acid-base equilibrium and electrolyte content in patients with liver cirrhosis and ascites].
Loginov AS; Sakharova TN
Sov Med; 1976 Dec; (12):53-9. PubMed ID: 1013792
[No Abstract] [Full Text] [Related]
38. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
Fraisse H; Perret M; Etaix JP
J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
[No Abstract] [Full Text] [Related]
39. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
[TBL] [Abstract][Full Text] [Related]
40. [Urinary excretion of magnesium in patients with liver cirrhosis treated with oral diuretics. Its variation through vasopressin].
Bardi A; Merino I; Rendic Y; Generini G
Rev Med Chil; 1968 Jun; 96(6):415-9. PubMed ID: 5730619
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
